Real world data on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) use in advanced/metastatic non-small cell lung cancer (NSCLC) with EGFR mutations in Singapore

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Real World Data ◽

The quantitatively analysis of epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) and its correlation with response rate of EGFR tyrosine kinase inhibitors (TKI)

10.1158/diag-10-pr10 ◽

2010 ◽

Cited By ~ 1

Author(s):

Jun Li ◽

Zhao Chen ◽

Daqiang Sun ◽

Meilin Xu ◽

Xun Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitors ◽

Response Rate ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Uncommon epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer and sensitivity to EGFR tyrosine kinase inhibitors, a two centers experience

Annals of Oncology ◽

10.1093/annonc/mdw332.20 ◽

2016 ◽

Vol 27 ◽

pp. iv9

Author(s):

M. Bonomi ◽

L. Bonomi ◽

M.G. Sauta ◽

A.C. Bettini ◽

M. Squadroni ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Distinct Clinical Outcomes of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor (EGFR) Mutations Treated with EGFR Tyrosine Kinase Inhibitors: Non-Responders versus Responders

PLoS ONE ◽

10.1371/journal.pone.0083266 ◽

2013 ◽

Vol 8 (12) ◽

pp. e83266 ◽

Cited By ~ 3

Author(s):

Shih-Hsin Hsiao ◽

H. Eugene Liu ◽

Hsin-Lun Lee ◽

Chii-Lan Lin ◽

Wei-Yu Chen ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer harboring uncommon EGFR mutations: Focus on afatinib

Seminars in Oncology ◽

10.1053/j.seminoncol.2019.08.004 ◽

2019 ◽

Vol 46 (3) ◽

pp. 271-283 ◽

Cited By ~ 19

Author(s):

Ashiq Masood ◽

Rama Krishna Kancha ◽

Janakiraman Subramanian

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

A retrospective analysis of patients (pts) with non-small-cell lung cancer (NSCLC) with uncommon or complex epidermal growth factor receptor (EGFR) mutations treated with tyrosine kinase inhibitors (EGFR-TKIs): clinical features and outcome

Annals of Oncology ◽

10.1093/annonc/mdx426.006 ◽

2017 ◽

Vol 28 ◽

pp. vi56

Author(s):

I. Stasi ◽

A. Farnesi ◽

E. Vasile ◽

I. Petrini ◽

M. Luccchesi ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Epidermal Growth ◽

Egfr Tkis

Clinical Significance of Disease Flares in Patients with Non-small Cell Lung Cancer with Positive EGFR Mutations Following the Suspension of Treatment with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

Haigan ◽

10.2482/haigan.54.1 ◽

2014 ◽

Vol 54 (1) ◽

pp. 1-5 ◽

Cited By ~ 1

Author(s):

Ai Yamamoto ◽

Kazutoshi Isobe ◽

Kyohei Kaburaki ◽

Arisa Kinoshita ◽

Tomohiro Wada ◽

...

Keyword(s):

Lung Cancer ◽

Receptor Tyrosine Kinase Inhibitors

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Epidermal Growth ◽

Expression of insulin-like growth factor 1 receptor (IGF-1R) predicts poor responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer patients harboring activating EGFR mutations

Lung Cancer ◽

10.1016/j.lungcan.2015.01.004 ◽

2015 ◽

Vol 87 (3) ◽

pp. 311-317 ◽

Cited By ~ 31

Author(s):

Chang Dong Yeo ◽

Ki Hoon Park ◽

Chan Kwon Park ◽

Sang Haak Lee ◽

Seung Joon Kim ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Uncommon mutation types of epidermal growth factor receptor and response to EGFR tyrosine kinase inhibitors in Chinese non-small cell lung cancer patients

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-017-3464-9 ◽

2017 ◽

Vol 80 (6) ◽

pp. 1179-1187 ◽

Cited By ~ 7

Author(s):

Kaiyan Chen ◽

Xiaoqing Yu ◽

Haiyang Wang ◽

Zhiyu Huang ◽

Yanjun Xu ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study

Annals of Oncology ◽

10.1093/annonc/mdt127 ◽

2013 ◽

Vol 24 (8) ◽

pp. 2080-2087 ◽

Cited By ~ 61

Author(s):

J.K. Lee ◽

J.-Y. Shin ◽

S. Kim ◽

S. Lee ◽

C. Park ◽

...

Keyword(s):

Lung Cancer ◽

Exploratory Study ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Primary Resistance ◽

Epidermal growth factor receptor (EGFR) exon 20 mutations in non-small-cell lung cancer and resistance to EGFR-tyrosine kinase inhibitors

Investigational New Drugs ◽

10.1007/s10637-014-0146-x ◽

2014 ◽

Vol 32 (6) ◽

pp. 1311-1315 ◽

Cited By ~ 16

Author(s):

Hyun Sun Woo ◽

Hee Kyung Ahn ◽

Ha Yeon Lee ◽

Inkeun Park ◽

Young Saing Kim ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Exon 20